Azhar Ali

1.6k total citations · 1 hit paper
33 papers, 1.2k citations indexed

About

Azhar Ali is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Azhar Ali has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Cell Biology. Recurrent topics in Azhar Ali's work include BRCA gene mutations in cancer (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Azhar Ali is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Azhar Ali collaborates with scholars based in Singapore, United States and Malaysia. Azhar Ali's co-authors include Chee Wai Fhu, Sai Kiang Lim, Yew Koon Lim, Siew Meng Chong, Hongkyun Kim, Frank Costantini, Shen Kiat Lim, Yanping Wang, Qian Zhang and Tan Min Chin and has published in prestigious journals such as Blood, PLoS ONE and FEBS Letters.

In The Last Decade

Azhar Ali

31 papers receiving 1.2k citations

Hit Papers

Fatty Acid Synthase: An Emerging Target in Cancer 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fatty Acid Synthase: An Emerging Target in Cancer
    2020 279 citations Chee Wai Fhu, Azhar Ali profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Azhar Ali Singapore 16 635 383 235 136 131 33 1.2k
Leilei Du China 19 583 0.9× 330 0.9× 61 0.3× 143 1.1× 122 0.9× 47 1.2k
Ravinder Tammali United States 19 637 1.0× 177 0.5× 611 2.6× 129 0.9× 116 0.9× 34 1.2k
Geetha M. Habib United States 17 1.3k 2.0× 172 0.4× 119 0.5× 180 1.3× 131 1.0× 30 2.0k
Nancy B. Kuemmerle United States 18 816 1.3× 557 1.5× 72 0.3× 89 0.7× 133 1.0× 39 1.4k
Michiel Adriaens Netherlands 18 715 1.1× 245 0.6× 55 0.2× 181 1.3× 105 0.8× 57 1.3k
Wai‐Nang Paul Lee United States 19 831 1.3× 511 1.3× 39 0.2× 142 1.0× 129 1.0× 28 1.4k
Véronique Bourgarel‐Rey France 22 526 0.8× 152 0.4× 209 0.9× 66 0.5× 277 2.1× 30 1.1k
Frank K. Jugert Germany 18 467 0.7× 117 0.3× 127 0.5× 100 0.7× 200 1.5× 35 1.4k
Sarah P. Short United States 18 605 1.0× 176 0.5× 116 0.5× 62 0.5× 251 1.9× 45 1.2k
Winnie Luu Australia 15 655 1.0× 282 0.7× 135 0.6× 84 0.6× 72 0.5× 21 1.1k

Countries citing papers authored by Azhar Ali

Since Specialization
Citations

This map shows the geographic impact of Azhar Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azhar Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azhar Ali more than expected).

Fields of papers citing papers by Azhar Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azhar Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azhar Ali. The network helps show where Azhar Ali may publish in the future.

Co-authorship network of co-authors of Azhar Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Azhar Ali. A scholar is included among the top collaborators of Azhar Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azhar Ali. Azhar Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirpara, Jayshree L., Win Lwin Thuya, Jie Qing Eu, et al.. (2024). Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance. Theranostics. 14(16). 6350–6369. 2 indexed citations
2.
3.
4.
Neo, Soek-Ying, Yaqian He, Yi-Chen Tsai, et al.. (2023). Effects of Leea indica leaf extracts and its phytoconstituents on natural killer cell-mediated cytotoxicity in human ovarian cancer. BMC Complementary Medicine and Therapies. 23(1). 79–79. 8 indexed citations
5.
How, Chee Wun, et al.. (2023). Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing. Pharmaceuticals. 16(3). 451–451. 16 indexed citations
6.
Fhu, Chee Wai & Azhar Ali. (2021). Protein Lipidation by Palmitoylation and Myristoylation in Cancer. Frontiers in Cell and Developmental Biology. 9. 673647–673647. 44 indexed citations
7.
Gandhi, T. K. B., Ellen P.S. Man, John G. Clohessy, et al.. (2020). Targeting microtubule sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors. Theranostics. 10(6). 2727–2743. 7 indexed citations
8.
Ali, Azhar, et al.. (2019). Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells. European Journal of Medicinal Chemistry. 182. 111597–111597. 20 indexed citations
9.
Ali, Azhar, Elena Levantini, Chee Wai Fhu, et al.. (2019). CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer. Theranostics. 9(21). 6157–6174. 34 indexed citations
10.
Ali, Azhar, Elena Levantini, Julian Goggi, et al.. (2018). Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer. EMBO Molecular Medicine. 10(3). 138 indexed citations
11.
Neo, Soek-Ying, et al.. (2018). Evaluation of anti-proliferative activity of medicinal plants used in Asian Traditional Medicine to treat cancer. Journal of Ethnopharmacology. 235. 75–87. 42 indexed citations
12.
Nin, Dawn Sijin, Azhar Ali, Kōichi Okumura, et al.. (2013). Akt-Induced Phosphorylation of N-CoR at Serine 1450 Contributes to Its Misfolded Conformational Dependent Loss (MCDL) in Acute Myeloid Leukemia of the M5 Subtype. PLoS ONE. 8(8). e70891–e70891. 4 indexed citations
13.
14.
Ali, Azhar, et al.. (2007). BRCA1 disease-associated haplotypes in Singapore Malay women with early-onset breast/ovarian cancer. Breast Cancer Research and Treatment. 104(3). 351–353. 4 indexed citations
15.
Ali, Azhar, et al.. (2007). Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. Clinical Genetics. 71(4). 331–342. 45 indexed citations
16.
Ali, Azhar, et al.. (2006). The founder mutationBRCA1c.2845insA identified in a fallopian tube cancer patient: a case report. International Journal of Gynecological Cancer. 16(S1). 362–365. 1 indexed citations
17.
Tai, E Shyong, Azhar Ali, Qian Zhang, et al.. (2003). Hepatic expression of PPARα, a molecular target of fibrates, is regulated during inflammation in a gender‐specific manner. FEBS Letters. 546(2-3). 237–240. 20 indexed citations
18.
Lim, Yew Koon, et al.. (2002). Gonadal effects on plasma ACE activity in mice. Atherosclerosis. 160(2). 311–316. 29 indexed citations
19.
Lim, Yew Koon, Andrew M. Jenner, Azhar Ali, et al.. (2000). Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis. Kidney International. 58(3). 1033–1044. 91 indexed citations
20.
Lim, Sai Kiang, et al.. (2000). An anemic patient with phenotypical ?-thalassemic trait has elevated level of structurally normal ?-globin mRNA in reticulocytes. American Journal of Hematology. 65(3). 243–250. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leilei Du Breakdown of academic impact, for papers by Ravinder Tammali Breakdown of academic impact, for papers by Geetha M. Habib Breakdown of academic impact, for papers by Nancy B. Kuemmerle Breakdown of academic impact, for papers by Michiel Adriaens Breakdown of academic impact, for papers by Wai‐Nang Paul Lee Breakdown of academic impact, for papers by Véronique Bourgarel‐Rey Breakdown of academic impact, for papers by Frank K. Jugert Breakdown of academic impact, for papers by Sarah P. Short Breakdown of academic impact, for papers by Winnie Luu
Rankless by CCL
2026